Skip to main content

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding CalciMedica, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of CALC: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders21124+4
Shares2.97M13.2K3.06M+100.9K (+3.4%)
Value$11.8M$52.4K$13.6M+$1.83M (+15.6%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held CalciMedica, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CALC in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.16,066$71.2K0.00%
PVG Asset Management Corp15,115$67.0K0.27%
Cetera Investment Advisers12,307$54.5K0.00%
Connective Capital Management, LLC10,000$37.0K0.03%
Royal Bank of Canada250$1.00K0.00%
Federation des caisses Desjardins du Quebec200$8860.00%

Sold out (2)

Institutions that held CalciMedica, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CALC in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Tower Research Capital LLC (TRC)921$4.61K
Qube Research & Technologies Ltd1$4

Not filed for Q3 2024 yet (1)

Institutions that held CalciMedica, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CALC in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.13,242$52.4K